Press Releases

 Filter by Provider

The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Anadarko Securities Litigation:

Centralized Supply Chain Services, LLC (CSCS®), together with Applebee’s® and IHOP®, have named Pacific Prime Meats and Custom Foods of America their 2026 Supplier Partners of the Year, honoring the companies for their collaboration, innovation, and commitment to supporting restaurant success across the Applebee’s and IHOP systems. The awards were presented at the Applebee’s Franchise Conference and IHOP Supplier Summit in Austin, Texas.

NEW ALBANY, Ohio, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Abercrombie & Fitch Co. (NYSE: ANF) will host its quarterly earnings conference call for all interested parties on Tuesday, November 24, 2026, at 8:30 a.m. ET. A press release detailing the company’s third quarter results is expected to be issued shortly after 7:30 a.m. ET.   In addition, a presentation of the third quarter results will be available on the company’s website at approximately 7:30 a.m. ET.

The OVIN Report identifies commercial-to-defense adaptation, autonomous systems, testing and trusted supply chains as priorities that management considers relevant to the Company's existing operations

Parties agree in principle to pursue acquisition of 100% of Tranglo, subject to definitive documentation and agreement with Ripple Markets APAC

Move supports the company’s long-term growth strategy and goal of pursuing a listing on the Nasdaq Stock Exchange

Completed enrollment in Phase 3 UPSTREAM MG trial of telitacicept in generalized myasthenia gravis; topline results remain on track for 1H27

HOUSTON, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Fervo Energy (“Fervo” or the “Company”) (NASDAQ: FRVO), a global pioneer of next-generation geothermal energy, today announced that it will release third quarter 2026 financial and operational results before the market opens on Monday, November 9, 2026. The Company will host a webcast and conference call that same day at 10:00 a.m. ET (9:00 a.m. CT) to discuss the results.

New distribution agreement positions TULSA-PRO within the iMRI Suite offering through Cook Medical’s Copernicus™ program, expanding Profound’s commercial reach

Launching a new premium cookware line or refreshing seasonal kitchenware listings on Shopify and Amazon often hits an expensive operational wall. Traditional studio photography requires shipping heavy cast iron dutch ovens, staging elaborate kitchen countertops, and waiting weeks for edited proofs. When e-commerce teams turn to generative visual tools to…

CLEARWATER, Fla. - Traffic accidents involving motorcycles, pedestrians, and commercial trucks can leave injured individuals facing medical expenses, lost income, and uncertainty about their legal options. Tragos, Sartes & Tragos, a Clearwater, Florida, law firm, provides information to help individuals understand personal injury claims and the legal considerations that may follow…

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) --

CLEARWATER, Fla. - Serious accidents, suspected medical negligence, and criminal allegations can create difficult legal questions for individuals and families. Tragos, Sartes & Tragos, a Clearwater, Florida, law firm, provides information about these legal matters to help people better understand the issues involved and identify potential next steps. When a fatal…

NIAID-RNCP elects to evaluate the efficacy of Entolimod on gastrointestinal acute radiation syndrome ("GI-ARS"), after the announcement of positive safety findingsFully funded study will evaluate Entolimod's potential to improve survival rates and gastrointestinal ("GI") tissue recovery following radiation exposureTop-line results anticipated in early December, providing the next key development milestone for Valion Bio's lead biologic drug candidate and, if positive, will further support Entolimod's potential role in government preparedness for radiological and nuclear mass-casualty scenarios

104th Annual Italian American Awards Gala will Feature Mike Del Pozzo, President of PepsiCo US Beverages, Who Will Receive the Prestigious Lifetime Achievement Award at UNICO's Signature Celebration of Heritage, Service and Excellence

From skin and joint health to hydration and metabolic wellness, discover how multifunctional collagen formulas go beyond traditional beauty support.

- Agreement complements revenue from standard gene expression and DRP® services

Transaction in Own Shares

OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today reported financial results for the three and nine months ended September 30, 2026, provided operating and partner program progress, and updated 2026 financial guidance.

MONTREAL, Oct. 30, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today that its Board of Directors has approved a fourth-quarter 2026 dividend on the Company’s common shares outstanding. A quarterly dividend of ninety-one and a half cents (C$0.9150) per common share will be paid on December 30, 2026, to shareholders of record at the close of business on December 9, 2026.

Pretzel Therapeutics, Inc., a clinical-stage biotechnology company advancing a new class of medicines designed to restore mitochondrial function, improve cellular energetics and impede disease progression across a range of neurological and rare diseases, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the company’s clinical trial application for PX578, the company’s lead therapeutic candidate being developed for patients with POLG-mediated mitochondrial disorders (POLG disease), a rare, progressive genetic disorder caused by mutations in the POLG gene causing a depletion of mitochondrial DNA.

Trane Technologies (NYSE: TT), a global climate innovator, brings together engineers, innovators and industry leaders for bold conversations at the forefront of sustainable technology in Season 6 of the Healthy Spaces Podcast. Co-hosted by Trane Technologies leaders Scott Tew, Vice President and Global Head of Sustainability Strategy, and Dominique Silva, Marketing Leader for Europe, Middle East and Africa, this season explores the pivotal moment when breakthrough ideas move beyond research and begin delivering real-world impact across industries.

LCI Industries (NYSE: LCII) (“LCI”), today announced that its Board of Directors, in consultation with its outside financial and legal advisors, has unanimously determined that the unsolicited, non-binding proposal received from Monomoy Capital Partners to acquire LCI for $101 per share in cash does not constitute a superior proposal and is not reasonably likely to lead to a superior proposal.

Dominion Energy, Inc. (NYSE: D), today announced unaudited net income determined in accordance with Generally Accepted Accounting Principles (GAAP, or reported earnings) for the three months ended Sept. 30, 2026, of $1.2 billion ($1.30 per share) compared with net income of $1.0 billion ($1.16 per share) for the same period in 2025.

Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for varegacestat, an investigational, oral, once-daily gamma secretase inhibitor (GSI), for the treatment of adults with desmoid tumors. Validation confirms that the application is complete, and the EMA will initiate review under the centralized marketing authorization procedure.

MONTREAL, Oct. 30, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) today reported its financial and operating results for the third quarter ended September 30, 2026.

SAN FRANCISCO, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases, today announced that it will host an investor and analyst webinar on Friday, November 6, 2026, from 4:35 p.m. to 6:05 p.m. ET. The event will feature remarks on Braveheart Bio's cardiac myosin inhibitor program and the global clinical development of BHB-1893 in patients with obstructive HCM and non-obstructive HCM from Management and the following speakers:

SAN FRANCISCO, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases, today announced two upcoming presentations, including a late-breaking presentation of 52-week extension data for BHB-1893 in obstructive HCM, at the American Heart Association (AHA) Scientific Sessions 2026, taking place November 6-9, 2026, in Chicago, IL. Following the presentations, copies of the presentation materials will be available in the Investors section of the Braveheart Bio website.

Measured and Indicated silver up 189% to 38.8 Moz (10.4 Mt at 117 g/t Ag) and Inferred silver of 120.1 Moz (21.6 Mt at 171 g/t Ag)Certain figures revised from the September 22, 2026 news release; tonnages and resource classification are unchanged(All dollar amounts expressed in US dollars unless otherwise noted)

Genworth Financial, Inc. (NYSE: GNW) today announced that Tom McInerney has notified the Board of Directors of his decision to retire as President & Chief Executive Officer and step down from Genworth’s Board of Directors, effective December 31, 2026. At that time, the Board of Directors expects to name Jerome Upton, currently Genworth’s Chief Financial Officer, as President and CEO and appoint him to Genworth’s Board of Directors. Angela Simmons, currently Chief Financial Officer of Genworth’s Closed Block, is expected to become Executive Vice President and Chief Financial Officer.

TORONTO, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Celestica Inc. (NYSE: CLS) (TSX: CLS), a global leader in data center infrastructure and advanced technology solutions, today announced that the Toronto Stock Exchange (the “TSX”) has accepted the Company's notice to launch a Normal Course Issuer Bid (the “Bid”).

Shanghai Coordination Center of World Cities Day

Organising Committee of Global Observance of World Cities Day

Highlights

KNOXVILLE, TENNESSEE - October 30, 2026 - Tennessee Complete Barndo Solutions, a Knoxville-based builder of turnkey barndominiums, has announced that it has expanded its capacity to take on more projects across Tennessee. The company has been building custom barndominiums and metal-framed homes throughout the state and has now freed up room in its schedule to begin additional builds in East, Middle and West Tennessee.

VANCOUVER, BC / ACCESS Newswire / October 30, 2026 / Aztec Minerals Corp. (TSXV:AZT)(OTCQB:AZZTF) ("Aztec" or the "Company") announces the strengthening of its technical management team with the appointment of Curtis Ferron, P.Geo., M.Sc., as Vice President, Technical Services, and the promotion of Ivan Valencia to Exploration Manager. Both appointments are effective November 1, 2026.

Company continues to own and operate its business in Taiwan; believes it has regained compliance with the Nasdaq stockholders' equity requirement

Enhertu® (trastuzumab deruxtecan) has been awarded the 2026 International Prix Galien Award for Best Biotechnology Product, a recognition awarded every two years by The Galien Foundation. This is the second award granted to Enhertu, following receipt of the Prix Galien USA Award for Best Biotechnology Product in 2024.

AstraZeneca:

Latus Bio, Inc. (Latus), a biotechnology company engineering gene therapies at scale, today announced new preclinical data presented at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress, held October 27-30, 2026, in Hamburg, Germany. The posters showcased the ability of Latus’ integrated discovery engine to generate differentiated, engineered AAV gene therapies for central nervous system (CNS) and peripheral tissues, including new preclinical data on proprietary pan-neuronal and kidney-targeting capsid variants with superior performance relative to AAV9. The poster presentations also highlighted investigational gene therapy programs for Huntington's disease (HD) (LTS-201) and CLN2 Batten disease (LTS-101) that are enabled by previously disclosed engineered capsids.

Starboard Value LP (together with its affiliates, “Starboard”), a stockholder of Knife River Corporation (“Knife River” or the “Company”) (NYSE: KNF), today announced that it has delivered a letter to the Company’s Board of Directors.

Alkermes plc (Nasdaq: ALKS) today announced the initiation of a phase 2 study evaluating the safety and efficacy of ALKS 7290 as an adjunctive therapy to antidepressants in adult participants with major depressive disorder (MDD). ALKS 7290 is the company’s investigational orexin 2 receptor (OX2R) agonist in development for the treatment of attention-deficit hyperactivity disorder (ADHD) and for the adjunctive treatment of MDD.

Capri Holdings Limited (NYSE:CPRI), a global fashion luxury group, today announced its financial results for the second quarter of Fiscal 2027 ended September 26, 2026.

Flowco Holdings Inc. (NYSE: FLOC) (“Flowco” or the “Company”), a provider of production optimization, artificial lift and emissions management and monetization solutions for the oil and natural gas industry, today announced that its Board of Directors has approved a quarterly cash dividend of $0.09 per share of Class A common stock payable on November 24, 2026 to Class A common stockholders of record as of the close of business on November 13, 2026. Flowco MergeCo LLC, the Company’s operating subsidiary, will make a corresponding distribution of $0.09 per unit to holders of its common units.

A new address, the same Legit. Texas. Barbecue. Dickey’s Barbecue Pit made its move from Fort Collins to Longmont opening to the ‘cue-mmunity on Thursday, October 29, with plans for a community celebration featuring special deals on barbecue favorites on Saturday, November 7.

Hess Midstream LP (NYSE: HESM) (“Hess Midstream” or the “Company”) today reported third quarter 2026 net income of $179.1 million compared with net income of $175.5 million for the third quarter of 2025. After deduction for noncontrolling interests, net income attributable to Hess Midstream was $99.4 million, or $0.77 basic earnings per Class A share, compared with $0.75 basic earnings per Class A share in the third quarter of 2025. Hess Midstream generated Adjusted EBITDA of $319.9 million. Net cash provided by operating activities was $267.9 million and Adjusted Free Cash Flow was $247.9 million.

Oil States International, Inc. (NYSE: OIS):

BearingPoint and ABeam Consulting are marking the first anniversary of BearingPoint North America, their joint venture headquartered in Chicago. Established in September 2025, the joint venture builds on the companies’ strategic alliance dating back to 2011 and strengthens their ability to support clients across the Americas, Europe, and Asia through an integrated global delivery model.